Clinical Trial

Clinical Trial Search

Click here to learn more about participating in Clinical Trials.

Trial Protocol ID USOR 23177_1403-0019_Brightline-4 STAR On hold effective 06/18/2024

Trial Description

Brightline-4: A Phase III open-label, single-arm, multi-center study to assess the safety and efficacy of brigimadlin (BI 907828) treatment in patients with treatment-naive or pre-treated advanced dedifferentiated liposarcoma

View on ClinicalTrials.gov

Disease Types

Solid Tumors

ClinicalTrials.gov NCT ID

NCT06058793